---
title: "Insulin Glargine - Diabetes Mellitus Type 2"
sidebar: mydoc_sidebar
permalink: db00047-mesh-d003924-1.html
toc: false 
---


Path ID: `DB00047_MESH_D003924_1`
{% include image.html url="images/db00047-mesh-d003924-1.png" file="db00047-mesh-d003924-1.png" alt="db00047-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069036 | Insulin glargine | Drug |
| UniProt:P06213 | Insulin receptor | Protein |
| GO:0019216 | Lipid metabolism | BiologicalProcess |
| GO:0051246 | Protein metabolism | BiologicalProcess |
| GO:0004713 | Tyrosine kinase activity | BiologicalProcess |
| REACT:R-HSA-198203 | PI3K/AKT activation | Pathway |
| GO:0010906 | Glucose metabolism | BiologicalProcess |
| MESH:D001786 | Blood glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Insulin Glargine | INCREASES ACTIVITY OF | Insulin Receptor |
| Insulin Receptor | POSITIVELY CORRELATED WITH | Tyrosine Kinase Activity |
| Tyrosine Kinase Activity | POSITIVELY REGULATES | Pi3K/Akt Activation |
| Pi3K/Akt Activation | REGULATES | Glucose Metabolism |
| Glucose Metabolism | DECREASES ABUNDANCE OF | Blood Glucose |
| Pi3K/Akt Activation | REGULATES | Lipid Metabolism |
| Lipid Metabolism | DECREASES ABUNDANCE OF | Blood Glucose |
| Pi3K/Akt Activation | REGULATES | Protein Metabolism |
| Protein Metabolism | DECREASES ABUNDANCE OF | Blood Glucose |
| Blood Glucose | CAUSES | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00047#mechanismofaction](https://go.drugbank.com/drugs/DB00047#mechanismofaction)
